简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2023-03-09 09:45 Medidata Drives Diversity in Clinical Trials, Passing 30,000 Studies and 9 Million Participants
2023-03-08 19:11 Biocytogen Announces RenLite™ Licensing Agreement with Janssen
2023-03-08 18:44 Clifford Hallam Healthcare Selects Rimini Consult™ Professional Services to Accelerate Business Targets Through Improved SAP System Operations
2023-03-08 12:51 New Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Adult Neurosurgical Patients
2023-03-07 19:31 Dr. Jack Kolenda from Toronto and Lux Vitae Worldwide Announce That The Steriwave Nasal Decolonization Treatment Has Been Successfully Used By The Rock Band KISS Since September of 2021, To Prevent The Transmission And Spread of Covid 19
2023-03-07 16:12 MRM Health Completes Patient Recruitment in Ulcerative Colitis Study, Secures Financing and Provides Outlook for 2023
2023-03-07 15:12 Oral-B® Announces Launch of THE BIG RETHINK, an Initiative to Make Oral Care More Inclusive, Accessible, and Positive for People With Disabilities, Their Caregivers, and Dental Professionals.
2023-03-06 09:27 Aptorum Group Announces Completion of Pre-IND Discussions with US FDA on its ALS-4, a First-in-Class Small Molecule Drug Targeting Methicillin Resistant Staphylococcus Aureus
2023-03-06 09:25 Aptorum Group Announces Completion of End of Phase 1 (EOP1) Meeting with US FDA on its SACT-1, a Repurposed Small Molecule Drug Targeting Neuroblastoma
2023-03-03 09:42 Aptorum Group Launches NativusWell®, a Novel Nutraceutical for Menopause, in China
2023-03-02 19:24 Aleph Farms Increases Production Capabilities with VBL Therapeutics Facility Acquisition and ESCO Aster Partnership
2023-03-01 16:47 Joe Kiani Provides Keynote at the 5th Annual Global Ministerial Summit on Patient Safety
2023-03-01 15:33 Microba Launches Next Generation Healthcare Testing
2023-03-01 15:22 GE HealthCare Announces Completion of Phase I Subject Recruitment in Early Clinical Development Program for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent
2023-02-28 10:20 Biocytogen’s Subsidiary Eucure Biopharma and Chipscreen Biosciences’ Holding Subsidiary Chipscreen NewWay Biosciences Enter into Greater China License Agreement for Bispecific Antibody YH008
2023-02-24 11:02 Accutar Biotechnology Announces First Patient Dosed in China with AC0176 in Phase 1 Study in Prostate Cancer
2023-02-24 09:49 Merck Highlights New Four-Year Efficacy and Safety Data for Investigational BTK Inhibitor, Evobrutinib, in RMS
2023-02-23 14:57 Ferrer Acquires Worldwide Rights to ASN90, an O-GlcNAcase Inhibitor From Asceneuron, Exclusively to Treat Progressive Supranuclear Palsy (PSP)
2023-02-23 14:44 Sinovac Amends Shareholder Rights Plan
2023-02-23 11:44 Exscientia to Present at Upcoming Investor Conferences in March

Business Wire Weibo

Press Releases

Latest Releases